# The dynamics of chemoattractant receptors redistribution in the electrotaxis of 3T3 fibroblasts

**Authors:** Jagoda Gorzkowska, Wiktoria Kozak, Sylwia Bobis-Wozowicz, Ivan Cherepashuk, Zbigniew Madeja, Sławomir Lasota

PMC · DOI: 10.1186/s12964-025-02165-4 · Cell Communication and Signaling : CCS · 2025-04-08

## TL;DR

This study explores how electric fields influence the movement of 3T3 fibroblasts by examining the redistribution of specific cell surface receptors.

## Contribution

The study provides new insights into the biphasic mechanism of electrotaxis involving EGFR redistribution and its role in long-term cell movement.

## Key findings

- EGFR redistributes to the cathode in response to dcEF, with maximum asymmetry after 30–40 minutes.
- EGFR redistribution is more pronounced at higher electric field intensities and under alkaline conditions.
- EGFR and ErbB4 are important for electrotaxis, but not for the fastest response, which is Kir-dependent.

## Abstract

Electrotaxis, the directed cell movement in direct current electric field (dcEF), is crucial for wound healing and development. We recently proposed a biphasic electrotaxis mechanism, where an initial rapid response is driven by ionic mechanisms, while redistribution of membrane components come into play during prolonged exposure to dcEF.

To verify this hypothesis, we studied the redistribution dynamics of EGFR, PDGFRα/β, and TGFβR1 in dcEF. For this purpose, we utilized cells transfected with plasmids encoding fluorescently tagged receptors, which were exposed to dcEF in a custom-designed electrotactic chamber. Fluorescent images were captured using wide-field or TIRF microscopy, enabling precise quantitative analysis of receptor redistribution. Additionally, the functional significance of these selected receptors in electrotaxis was evaluated by silencing their expression using an siRNA library.

Although EGFR moved immediately to cathode after dcEF application, maximum distribution asymmetry was reached after 30–40 min. This process was more efficient at higher dcEF intensities, specifically, asymmetry was greater at 3 V/cm compared to 1 V/cm, consistent with the biphasic mechanism observed only under the stronger dcEF. Additionally, redistribution was more effective under alkaline conditions and near the cell base, but decreased when glass was coated with poly-L-lysine, indicating electroosmosis as a key factor. Importantly, EGFR redistribution did not correlate with the rapid reaction of 3T3 cells to dcEF reversal, which occurred within 1–2 min, when receptor orientation was not yet reversed. PDGFRα exhibited similar but less marked cathodal redistribution, while PDGFRβ and TGFβR1 did not redistribute. siRNA knockdown experiments confirmed the importance of EGFR and ErbB4 in the electrotaxis. EGFR’s role was largely ligand-independent, and it had a significant impact on the response of 3T3 cells to dcEF during the first hour of the experiment, but was not involved in the fastest response, which was Kir-dependent.

Our study suggests that EGFR redistribution may play a role in the early stages and partially contribute to the long-term electrotaxis of 3T3 fibroblasts. However, this mechanism alone does not fully explain rapid responses to dcEF orientation changes indicating a more complex, multimodal mechanism of electrotaxis in these cells.

The online version contains supplementary material available at 10.1186/s12964-025-02165-4.

## Linked entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956], PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156], PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159], TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046], ERBB4 (erb-b2 receptor tyrosine kinase 4) [NCBI Gene 2066], GEM (GTP binding protein overexpressed in skeletal muscle) [NCBI Gene 2669]
- **Chemicals:** poly-L-lysine (PubChem CID 58592376)

## Full-text entities

- **Genes:** Erbb4 (erb-b2 receptor tyrosine kinase 4) [NCBI Gene 13869] {aka Her4, c-erbB-4}, Pdgfrb (platelet derived growth factor receptor, beta polypeptide) [NCBI Gene 18596] {aka CD140b, PDGFR-1, Pdgfr}, Pdgfra (platelet derived growth factor receptor, alpha polypeptide) [NCBI Gene 18595] {aka CD140a, Pdgfr-2}, Tgfbr1 (transforming growth factor, beta receptor I) [NCBI Gene 21812] {aka ALK5, Alk-5, ESK2, TGFR-1, TbetaR-I, TbetaRI}, Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}
- **Chemicals:** poly-L-lysine (-)
- **Cell lines:** 3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11980103/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11980103/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC11980103/full.md

---
Source: https://tomesphere.com/paper/PMC11980103